2023 Q1 Form 10-Q Financial Statement

#000165495423012628 Filed on October 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q1
Revenue $2.211M
YoY Change -38.25%
Cost Of Revenue $2.746M
YoY Change 12.51%
Gross Profit -$535.4K
YoY Change -146.99%
Gross Profit Margin -24.22%
Selling, General & Admin $368.1K
YoY Change 3.43%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $224.2K
YoY Change 1.86%
% of Gross Profit
Operating Expenses $476.4K
YoY Change 32.41%
Operating Profit -$1.012M
YoY Change -229.8%
Interest Expense $197.4K
YoY Change 6518.04%
% of Operating Profit
Other Income/Expense, Net $204.9K
YoY Change 2970.62%
Pretax Income -$807.0K
YoY Change -203.51%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$807.0K
YoY Change -202.64%
Net Earnings / Revenue -36.5%
Basic Earnings Per Share $107.3M
Diluted Earnings Per Share -$0.01
COMMON SHARES
Basic Shares Outstanding 107.3M shares
Diluted Shares Outstanding 107.3M shares

Balance Sheet

Concept 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.62M
YoY Change -27.66%
Cash & Equivalents $15.36M
Short-Term Investments $259.9K
Other Short-Term Assets $279.5K
YoY Change
Inventory $1.610M
Prepaid Expenses
Receivables $1.704M
Other Receivables $0.00
Total Short-Term Assets $19.21M
YoY Change -20.26%
LONG-TERM ASSETS
Property, Plant & Equipment $12.52M
YoY Change 12.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.071M
YoY Change 277.44%
Total Long-Term Assets $13.65M
YoY Change 19.26%
TOTAL ASSETS
Total Short-Term Assets $19.21M
Total Long-Term Assets $13.65M
Total Assets $32.86M
YoY Change -7.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $835.7K
YoY Change -24.55%
Accrued Expenses $169.4K
YoY Change -72.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $95.57K
YoY Change 677.84%
Total Short-Term Liabilities $1.209M
YoY Change -30.69%
LONG-TERM LIABILITIES
Long-Term Debt $193.4K
YoY Change -2.71%
Other Long-Term Liabilities $396.8K
YoY Change -10.02%
Total Long-Term Liabilities $193.4K
YoY Change -2.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.209M
Total Long-Term Liabilities $193.4K
Total Liabilities $1.799M
YoY Change -24.53%
SHAREHOLDERS EQUITY
Retained Earnings -$33.88M
YoY Change 6.12%
Common Stock $1.076M
YoY Change 1.32%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00
YoY Change
Treasury Stock Shares
Shareholders Equity $31.06M
YoY Change
Total Liabilities & Shareholders Equity $32.86M
YoY Change -7.53%

Cashflow Statement

Concept 2023 Q1
OPERATING ACTIVITIES
Net Income -$807.0K
YoY Change -202.64%
Depreciation, Depletion And Amortization $224.2K
YoY Change 1.86%
Cash From Operating Activities -$2.274M
YoY Change -1487.28%
INVESTING ACTIVITIES
Capital Expenditures $614.8K
YoY Change 226.07%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$614.8K
YoY Change 226.07%
FINANCING ACTIVITIES
Cash Dividend Paid $787.7K
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $23.02K
YoY Change 467.46%
Cash From Financing Activities -$810.8K
YoY Change 19884.03%
NET CHANGE
Cash From Operating Activities -$2.274M
Cash From Investing Activities -$614.8K
Cash From Financing Activities -$810.8K
Net Change In Cash -$3.699M
YoY Change 12791.84%
FREE CASH FLOW
Cash From Operating Activities -$2.274M
Capital Expenditures $614.8K
Free Cash Flow -$2.889M
YoY Change 11624.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Assets
Assets
32861759 usd
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000101538
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107647317 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
106373341 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q1 us-gaap Increase Decrease In Coal Inventories
IncreaseDecreaseInCoalInventories
0 usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-08675
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
UNITED STATES ANTIMONY CORPORATION
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MT
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-0305822
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
P.O. Box 643
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Thompson Falls
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MT
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
59873
CY2023Q1 dei City Area Code
CityAreaCode
406
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
827-3523
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
UAMY
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
107647317 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15361064 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19060378 usd
CY2023Q1 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
259856 usd
CY2022Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
259857 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1704276 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
784457 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
1610216 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1375068 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
279451 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
137599 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
19214863 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
21617359 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12518653 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12128124 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
57288 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
57288 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1070955 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
897679 usd
CY2023Q1 us-gaap Assets
Assets
32861759 usd
CY2022Q4 us-gaap Assets
Assets
34700450 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
835652 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
628803 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
169422 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
201149 usd
CY2023Q1 uamy Due To Related Party Current
DueToRelatedPartyCurrent
92709 usd
CY2022Q4 uamy Due To Related Party Current
DueToRelatedPartyCurrent
72963 usd
CY2023Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
15884 usd
CY2022Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
435075 usd
CY2023Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
787730 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
95573 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
94150 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1209240 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2219870 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
193410 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
217855 usd
CY2023Q1 uamy Stock Payable To Directors For Services
StockPayableToDirectorsForServices
61459 usd
CY2022Q4 uamy Stock Payable To Directors For Services
StockPayableToDirectorsForServices
61459 usd
CY2023Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
335379 usd
CY2022Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
332011 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1799488 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2831195 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107647317 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
106373341 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1076472 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1063732 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63853836 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
64052630 usd
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
0 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
202980 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33877316 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33070332 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
31062271 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
31869255 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32861759 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34700450 usd
CY2023Q1 us-gaap Revenues
Revenues
2210844 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
2746263 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
2440918 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
-535419 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
1139388 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
155594 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
160681 usd
CY2023Q1 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
127692 usd
CY2022Q1 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
73135 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
108345 usd
CY2022Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3915 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
84806 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
122077 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
476437 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
359808 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1011856 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
779580 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
122372 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
9654 usd
CY2023Q1 uamy Income From Trademark And Licensing
IncomeFromTrademarkAndLicensing
7525 usd
CY2022Q1 uamy Income From Trademark And Licensing
IncomeFromTrademarkAndLicensing
0 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
74975 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2982 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
204872 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6672 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-806984 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
786252 usd
CY2023Q1 uamy Preferred Dividends
PreferredDividends
-1875 usd
CY2022Q1 uamy Preferred Dividends
PreferredDividends
-11819 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-808859 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
774432 usd
CY2023Q1 uamy Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.01
CY2022Q1 uamy Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
0.01
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107260472 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106240361 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107260472 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
106389761 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
32368803 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
786252 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
33155055 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
31869255 usd
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
0 usd
CY2023Q1 uamy Conversion Of Preferred Series D To Common Stock Amount
ConversionOfPreferredSeriesDToCommonStockAmount
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-806984 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
31062271 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-806984 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
786252 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
224241 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
220150 usd
CY2023Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
3368 usd
CY2022Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1732 usd
CY2023Q1 uamy Common Stock Payable For Directors Fees
CommonStockPayableForDirectorsFees
0 usd
CY2022Q1 uamy Common Stock Payable For Directors Fees
CommonStockPayableForDirectorsFees
28125 usd
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
246792 usd
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-919819 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-584539 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-481940 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
28440 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-141852 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
0 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-173275 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-41023 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
206849 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-278178 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-31727 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2944 usd
CY2023Q1 uamy Increase Decrease In Due To Related Party
IncreaseDecreaseInDueToRelatedParty
19746 usd
CY2022Q1 uamy Increase Decrease In Due To Related Party
IncreaseDecreaseInDueToRelatedParty
0 usd
CY2023Q1 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-419191 usd
CY2022Q1 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2273792 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
163903 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
614770 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
188541 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-614770 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-188541 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
23022 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4057 usd
CY2023Q1 uamy Dividends Paid
DividendsPaid
-787730 usd
CY2022Q1 uamy Dividends Paid
DividendsPaid
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-810752 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4057 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3699314 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-28695 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19117666 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21420329 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15418352 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21391634 usd
CY2023Q1 uamy Retirement Of Shares
RetirementOfShares
202980 usd
CY2022Q1 uamy Retirement Of Shares
RetirementOfShares
0 usd
CY2023Q1 uamy Conversion Of Preferred Series D To Common Stock
ConversionOfPreferredSeriesDToCommonStock
16927 usd
CY2022Q1 uamy Conversion Of Preferred Series D To Common Stock
ConversionOfPreferredSeriesDToCommonStock
0 usd
CY2023Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> <strong>NOTE 1 - NATURE OF OPERATIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">United States Antimony Corporation and its subsidiaries in the U.S. and Mexico (“USAC” or the “Company”) sell processed antimony, zeolite, and precious metals products in the U.S. and abroad. The Company processes antimony ore in the U.S. and Mexico primarily into antimony oxide and antimony metal at its facilities in Mexico and Montana. Our antimony oxide is used to form a flame-retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings and paper, as a color fastener in paint, and as a phosphorescent agent in fluorescent light bulbs. Our antimony metal is used in bearings, storage batteries, and ordnance. In its operations in Idaho, the Company mines and processes zeolite, a group of industrial minerals used in soil amendment and fertilizer, water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, animal nutrition, and other miscellaneous applications.</p>
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13147954 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12518653 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
17195914 usd
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2160805 usd
CY2022Q4 us-gaap Land
Land
5244177 usd
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
450941 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25051837 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12923713 usd
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain reclassifications have been made to conform prior period amounts to the current presentation. These reclassifications have no effect on the results of operations, stockholders’ equity and cash flows as previously reported. </p>
CY2023Q1 uamy Warrant Shares Purchase
WarrantSharesPurchase
149400 shares
CY2023Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
12346215 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
11092879 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12128124 usd
CY2023Q1 uamy Assets Not Yet Placed In Service
AssetsNotYetPlacedInService
1132474 usd
CY2022Q4 uamy Assets Not Yet Placed In Service
AssetsNotYetPlacedInService
1117041 usd
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1692672 shares
CY2023Q1 uamy Cash Paid To Shareholders
CashPaidToShareholders
787730 usd
CY2023Q1 uamy Description Of Returned Of Shares
DescriptionOfReturnedOfShares
the Company returned to treasury and cancelled 418,696 of its common shares which were repurchased prior to December 31, 2022 for $202,980
CY2023Q1 us-gaap Revenues
Revenues
2210844 usd
CY2022Q1 us-gaap Revenues
Revenues
3580306 usd
CY2023Q1 us-gaap Contract With Customer Receivable Allowance For Credit Loss
ContractWithCustomerReceivableAllowanceForCreditLoss
1704276 usd
CY2022Q4 us-gaap Contract With Customer Receivable Allowance For Credit Loss
ContractWithCustomerReceivableAllowanceForCreditLoss
784457 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
50000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
31440 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
1610216 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1375068 usd
CY2023Q1 us-gaap Increase Decrease In Coal Inventories
IncreaseDecreaseInCoalInventories
246792 usd
CY2023Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
17784100 usd
CY2023Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2160805 usd
CY2023Q1 us-gaap Land
Land
5274177 usd
CY2023Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
447525 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25666607 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
288983 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
312005 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
95573 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
94150 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
193410 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
217855 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
95573 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
20021 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
13144 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
160245 usd
CY2023Q1 uamy Long Term Debt Noncurrent Total
LongTermDebtNoncurrentTotal
288983 usd
CY2023Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
15884 usd
CY2022Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
435075 usd
CY2023Q1 uamy Royalty Obligation Descriptions
RoyaltyObligationDescriptions
the Company paid a royalty obligation related to the time period from 2016 to 2022 after finalizing its estimates
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
12346215 shares
CY2023Q1 uamy Warrants Exercised Exercise Price
WarrantsExercisedExercisePrice
0.75
CY2022Q4 us-gaap Assets
Assets
34700450 usd
CY2023Q1 uamy Capital Expenditure
CapitalExpenditure
614770 usd
CY2022Q1 uamy Capital Expenditure
CapitalExpenditure
188541 usd
CY2023Q1 us-gaap Revenues
Revenues
2210844 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
224241 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1011856 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
204872 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-806984 usd
CY2022Q1 us-gaap Revenues
Revenues
3580306 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
220150 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
779580 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6672 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
786252 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001654954-23-012628-index-headers.html Edgar Link pending
0001654954-23-012628-index.html Edgar Link pending
0001654954-23-012628.txt Edgar Link pending
0001654954-23-012628-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uamy-20230331.xsd Edgar Link pending
uamy_10q.htm Edgar Link pending
uamy_ex311.htm Edgar Link pending
uamy_ex312.htm Edgar Link pending
uamy_ex321.htm Edgar Link pending
uamy_ex322.htm Edgar Link pending
uamy-20230331_def.xml Edgar Link unprocessable
uamy-20230331_cal.xml Edgar Link unprocessable
uamy-20230331_pre.xml Edgar Link unprocessable
uamy-20230331_lab.xml Edgar Link unprocessable
uamy_10q_htm.xml Edgar Link completed